Jean-Claude Dehaes

Title: The Innovations of Jean-Claude Dehaes in Particle Therapy

Introduction

Jean-Claude Dehaes, an accomplished inventor based in Braine-le-Comte, Belgium, has made significant contributions to the field of medical technology. With a focus on charged hadron therapy, his work combines advanced engineering and medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Dehaes holds a patent for an "Apparatus for Particle Therapy Verification." This invention is crucial for verifying charged hadron therapy by detecting and quantifying prompt gamma rays produced when irradiating a target with a charged hadron beam. The apparatus features a collimator with a slit-shaped portion designed to position perpendicularly to the beam line and face the target. It includes a detection mechanism capable of identifying these prompt gammas and a calculation and representation system. The invention allows for the detection of gamma emissions from various depths within the target, creating a comprehensive dose-related distribution profile for multiple locations.

Career Highlights

Throughout his career, Jean-Claude Dehaes has worked with prominent organizations in the field. Notably, he has been involved with Ion Beam Applications S.A., a leader in hadrontherapy systems, and Université Libre de Bruxelles, where his academic and practical expertise flourished. His innovative work reflects a deep understanding of both theoretical and applied physics in medical settings.

Collaborations

Dehaes has collaborated with distinguished colleagues such as Damien Prieels and Frédéric Stichelbaut. Their joint efforts have contributed significantly to enhancing the capabilities and applications of particle therapy technologies, underlining the importance of teamwork in scientific advancements.

Conclusion

Jean-Claude Dehaes exemplifies the spirit of innovation in healthcare technology. His patent and collaborations reveal his commitment to improving medical treatments through advanced research and development. As the field of particle therapy continues to evolve, his contributions will likely play a pivotal role in the transformation of cancer treatment practices.